{
    "2019-11-01": [
        [
            {
                "time": "2019-01-01",
                "original_text": "The Zacks Analyst Blog Highlights: Citigroup, Novo Nordisk, BP, salesforce.com and TC Energy",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Citigroup",
                        "Novo Nordisk",
                        "BP",
                        "salesforce.com",
                        "TC Energy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance",
                        "energy",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-02",
                "original_text": "Novo Nordiskâ€™s Shares Are Rising Because Newer Diabetes Drugs Are Selling Well",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Shares Rising",
                        "Diabetes Drugs",
                        "Selling Well"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-03",
                "original_text": "UPDATE 2-Novo Nordisk nudges up 2019 sales outlook as new drugs excel",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "2019 sales outlook",
                        "new drugs",
                        "excel"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-04",
                "original_text": "Novo Nordisk nudges up 2019 sales outlook as new drugs excel",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "2019 sales outlook",
                        "new drugs",
                        "excel"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}